topic: Access to Medicines
Access to medicines: MSF demands Johnson & Johnson reduce price of lifesaving TB drug
MSF calls for new price of anti-TB drug delamanid to be lowered and offered outside of South Africa
Access to medicines: 6 things Big Pharma doesn’t want you to know!
MSF urges PM Modi not to make any trade commitments to US threatening access to medicines
Access to medicines: Gavi should stop awarding special funds to Pfizer and GSK for pneumonia vaccine
MSF’s patient-centred approach: Home-based TB care in Manipur
Ukraine: Effective drugs and patient support to combat Ukraine’s hepatitis C epidemic
UNAIDS update: High ongoing AIDS mortality reminds us that the fight against HIV is far from over
Gilead Sciences fails on promise to expand access to lifesaving drug for people living with HIV
